Kencoa Aerospace: A Value Study of an Aerostructures Supplier

Kencoa's current trouble is precisely what shows that "a good industry" does not equal "a good business." In its 2025 results commentary the company explicitly attributed the widening loss to falling revenue as the PTF business softened, a rising cost ratio, and an increase in non-operating expenses such as intangible-asset impairments. This indicates that when demand softened the company did not display strong pricing power or a low fixed-cost structure; instead it exposed the most typical fragility of project-based manufacturing: once aircraft-program cadence, customer plans, raw materials, labor, and inventory fall out of step, gross margin and cash flow erode quickly.

Business understandability score: 3/5. I can understand what it sells, who it sells to, and why there are barriers to entry; but if you ask whether, over the next decade, it will earn structurally high returns or merely cyclical ones, today's evidence is not yet enough. If the stock market were to close for five years, I would not be willing to hold a heavy position at the current price. More precisely, I am willing to track it over the long term, but I am not yet willing to treat it like a consumer monopoly—an "automatic compounding machine." Industry attractiveness also earns 3/5: the sector is decent and competitive barriers exist, but the chain is long, cyclicality is high, customers are concentrated, and cash flow is volatile.

Moat and Management

Broken down in the language of a long-term owner, Kencoa's moat exists, but it is not wide. It most resembles an industrial barrier formed by layering certification + supply-chain standing + cross-regional vertical capability, rather than a consumer brand, a platform network effect, or software lock-in. The company holds aviation quality-system certifications such as AS9100, its U.S. operations carry a Tier-1 supply record, and it can cover hard metals, specialty alloys, precision machining, structures, and assembly, having repeatedly entered Lockheed-, Boeing-, and NASA-related programs and supply chains, none of which can be replicated overnight. Lockheed's public cooperation and the company website's description of long-standing relationships with customers such as Boeing, Lockheed, Gulfstream, Spirit, and Airbus all support this.

But if you keep pressing: Does it have a brand advantage? No. Network effects? Almost none. Rigid switching costs? Limited. An overwhelming cost or scale advantage? The evidence is currently insufficient. Can it raise prices easily through inflation? At least in 2025 it could not. As revenue fell in 2025, the company's gross margin slid further from 11.1% in 2023 and 7.2% in 2024 to around 5.5%, and the operating margin dropped from 10.5% in 2022 to -12.1% in 2025. This looks more like a "supply-qualification moat" than a "high-bargaining-power moat."

More importantly, the moat has not translated into durably high returns on capital on the books. The company once delivered ROE of 10.18% and ROIC of 9.45% in 2022, but both fell back quickly across 2023-2025, with 2025 ROE at -9.01% and ROIC at -5.31%. If a moat is wide enough, it usually shows relatively steady profitability and repeated high-return capital deployment even through cyclical swings; Kencoa has not yet earned that report card. I therefore rate moat strength 2/5. It is not barrier-free, but it is a long way from a "durable competitive advantage."

On management, operating ability and capital-allocation ability must be assessed separately. Operationally, founder Kenneth M. Lee has a long track record in the distribution and manufacture of aerospace materials and components: he first founded California Metal, then established Korea's Kencoa in 2013, and in 2016 acquired Georgia-based HGMC in the United States, gradually building a dual-base Korea-U.S. platform. This résumé shows that his industrial resources and business-development ability are real.

On capital allocation, however, my assessment is markedly more conservative. The single most important item is the KRW 130 billion perpetual convertible bond financing of 2024. The company issued KRW 130 billion of perpetual CBs to Kepler/IMM-series entities at a 3% coupon and a conversion price of KRW 13,995; on the terms at the time, full conversion would add 9,289,031 shares, equivalent to 72.7% of the then-outstanding share count. In March 2025 the company further pushed the conversion start date of that CB to April 11, 2026. From a value investor's perspective, this means the balance sheet was significantly bolstered, but shareholders' per-share economic interest also faces considerable uncertainty.

Control of the company also changed. In April 2024 the largest shareholder shifted from founder Kenneth Minkyu Lee to Kepler, corresponding to a holding of roughly 3,548,261 shares, or 27.48%; yet the company's 2026 business report still shows Kenneth Minkyu Lee serving as representative director and running operations. Inference: operating continuity is intact, but the direct alignment of interest between management and ordinary shareholders is no longer as clean and simple as "a founder with a large stake who runs the business himself."

A more positive detail is that the company has not been issuing debt without restraint. Of the KRW 33 billion CB issued in 2023, the company disclosed that a substantial portion of the proceeds would be used to exercise the call option on an earlier CB, in order to reduce the latent selling pressure and overhang from older instruments—evidence that management is not wholly indifferent to capital structure. The problem is that the larger and more central KRW 130 billion perpetual CB of 2024 then pushed the dilution question right back to the fore. In other words, management is not unfamiliar with capital markets, but the path it insists on is "protect growth, protect expansion, protect capacity," not "prioritize the compounding of per-share intrinsic value." That is not friendly to conservative long-term value investors.

On balance, management and capital allocation score: 2/5. Operationally there is entrepreneurial and resource-integration ability; on disclosure, the company in 2025 candidly acknowledged the PTF downturn and the impairment issue. But from the standpoint of long-term ordinary shareholders, the reliance on external financing, the potential dilution, the change of control, and cash flow that has yet to prove itself all keep me from a higher mark.

Financial Quality and Owner Earnings

Start with the most important fact: across the three statements of reported profit, cash flow, and capital expenditure, Kencoa has not displayed the compounding trait of "getting stronger as it grows." Revenue grew from KRW 54.68 billion in 2021 to KRW 76.39 billion in 2025, a four-year compound growth rate of about 8.7%, which looks fine; but the path was anything but smooth, peaking at KRW 91.14 billion in 2023 before falling for two straight years back to KRW 76.39 billion in 2025. Gross margin slid all the way from 19.9% in 2022 to 5.5% in 2025, the operating margin slipped from 10.5% to -12.1%, and net income turned from a profit of KRW 3.24 billion in 2022 back to a loss of KRW 15.47 billion in 2025. This is not a "high-certainty rising-profit curve"; it is the textbook curve of a project-based manufacturer.

In the table, revenue, profit, gross margin, and total debt/share count come from an S&P Global-basis secondary financial database; operating cash flow and capex come from Investing's annual cash-flow data; free cash flow is calculated as "operating cash flow minus capex." (All figures in KRW billion except share counts.)

Viewed through the question of "whether profit is real cash profit," the problem is more severe than the income statement alone. In 2025 the company posted a net loss of KRW 15.47 billion, while trailing-twelve-month free cash flow remained negative KRW 26.68 billion; from 2021 through 2025 the company has run negative free cash flow for five straight years. Operating cash flow in 2025 did improve from negative KRW 22.61 billion in 2024 to negative KRW 0.62 billion, but that is more a "marked narrowing of cash outflow" than a "stable swing to positive." At the same time, 2025 capex still ran as high as KRW 26.06 billion. For a long-term owner, this means you are buying not a machine that already throws off cash steadily, but a machine that is still consuming capital and waiting to be validated.

Turnover data supports the same judgment. The company's inventory turnover fell from 2.56 in 2022 to 1.24 in 2025, and receivables turnover fell from 6.21 to 3.57. On the balance sheet, inventory rose from KRW 36.31 billion at the end of 2022 to KRW 62.12 billion at the end of 2025, even as revenue receded from its 2023 peak over the same period. Inference: at least over the past few years, this kind of growth has clearly relied on a buildup of working capital, and the efficiency of converting orders into cash has not been good.

The good news is that the first quarter of 2026 did show signs of improvement. Q1 2026 revenue was about KRW 29.22 billion, up roughly 45% year over year, with operating profit of about KRW 218 million, net income of about KRW 939 million, and operating cash flow of about KRW 1.815 billion; but quarterly capex was about KRW 2.636 billion, so quarterly free cash flow was still negative. At the same time, cash and short-term investments at the end of March 2026 totaled about KRW 27.46 billion, total debt about KRW 44.90 billion, and net debt about KRW 17.44 billion, an improvement over the end of 2025. Opinion: this is an improving thread worth continuing to track, but it falls short of "the business model has proven itself."

Now to returns on capital and debt service. In 2025 the company posted ROE of -9.01%, ROA of -2.38%, and ROIC of -5.31%, and interest coverage on a profit basis is not robust; from 2023 to 2025, operating-profit coverage of interest expense was weak or even negative. The current state is more like "liquidity safety" than "an imminent cash shortage," in part because the current ratio in 2025 and Q1 2026 has risen to around 3.04; but one point deserves special emphasis: this owes largely to external financing and balance-sheet expansion rather than internally generated cash. Total shareholders' equity was about KRW 58.41 billion at the end of 2023, jumped to KRW 183.32 billion at the end of 2024, and then fell back to KRW 160.35 billion in 2025; there are clear traces of financing-driven movement behind this. A low P/B therefore cannot be read automatically as cheap.

On accounting quality, I have not seen public material indicating an adverse or qualified audit opinion in 2025, nor any explicit going-concern uncertainty notice; at the same time, the company explained the 2025 deterioration with the downturn and asset impairment, which is better than papering over the cracks. Out of caution, however, I still treat "aggressive expansion + large impairment + cash flow markedly weaker than the profit target" as a medium-strength warning. This is not to say signs of fraud have been found; it is to say that a company like this requires investors to "watch the cash, watch the inventory, watch the receivables, watch the dilution" rather than watch only the order-book story.

On owner earnings, I will use a conservative basis. In 2025 the company's net income was negative KRW 15.47 billion; adding back depreciation and amortization of about KRW 7.51 billion, and considering that operating cash flow already incorporates working-capital changes, if I conservatively approximate maintenance capex at the level of depreciation and amortization, then 2025 "adjusted owner earnings" still sit roughly in the negative KRW 5 billion to negative KRW 8 billion range; on a strict free-cash-flow basis it is about negative KRW 26.68 billion. This means the current valuation cannot be supported by truly distributable historical cash flow. Put differently, the market is paying for "normalized cash flow that might appear in the future," not paying on "cash flow that has already been proven in the past."

Intrinsic Value and Margin of Safety

On valuation, I do not use the lazy "P/E only" method, because Kencoa is currently loss-making with negative free cash flow, so the P/E has no explanatory power on its own. A better approach is to treat it as a turnaround, small-cap, capital-heavy aerospace supplier with potential dilution, cross-checking three methods: discounted owner earnings, relative valuation, and asset value. The conclusion first: at the current price there is not enough margin of safety.

Within the discounted owner-earnings method, I must make an uncomfortable but necessary setup: current real owner earnings are negative, so I can only estimate "normalized owner earnings." My three scenarios are: the conservative scenario assumes a normalized owner-earnings starting point of KRW 6 billion, growth of 3% over the next ten years, a 12% discount rate, and 2% perpetual growth; the base scenario assumes a starting point of KRW 10 billion, 5% growth, a 10% discount rate, and 3% perpetual growth; the optimistic scenario assumes a starting point of KRW 15 billion, 7% growth, a 9% discount rate, and 3% perpetual growth. All three starting points are already more optimistic than the company's actual cash earnings in 2025; in effect they assume the company can recover and steadily achieve a better project mix, gross margin, and capex structure. On a rough per-share basis at the current share count, the corresponding per-share value lands at roughly KRW 4,800, KRW 12,400, and KRW 25,500. What matters here is not the point estimate but the direction: to make the current KRW 23,700 feel comfortable, you basically have to believe the optimistic scenario will come close to being realized.

This DCF also has a sterner reality check: under the base assumptions—a 10% discount rate, 5% ten-year growth, and 3% perpetual growth—back-solving the current KRW 325.2 billion market cap requires the company to start with sustainable owner earnings on the order of KRW 19 billion. Yet the best operating profit in the company's history was only KRW 7.99 billion in 2022, and 2025 strict free cash flow was still negative KRW 26.68 billion. Inference: the current price already embeds a fairly strong turnaround and delivery. For a conservative investor, that is not a sufficiently loose assumption.

The relative-valuation method likewise does not support "obviously cheap." The company's current P/B is about 1.94x, which on the surface is not high; but this is a P/B that follows the large increase in book capital from the KRW 130 billion perpetual CB in 2024, so "cheap on the books" does not equal "cheap on intrinsics." On a TTM basis, the company's P/S is about 3.6-3.7x; different platforms reach opposite conclusions using different comparison baskets: Investing's "peer/sector" comparison shows Kencoa's P/B below the peer average but its P/S above the broader peer/sector average, while another peer basket from Simply Wall St holds that the company's P/S is below its chosen peer average. My only judgment on this kind of contradictory relative valuation is this: it merely proves the peer set is poor; it is not enough to prove Kencoa is undervalued. For a company that is still loss-making, with negative FCF and a business model not yet fully proven, relative valuation was never strong evidence to begin with.

The asset/liquidation-value method gives a clearer floor anchor. At the end of March 2026, the company's tangible book value was about KRW 162.04 billion, or KRW 11,907 per share; tangible book per share at the end of 2025 was about KRW 11,543. Under harsher liquidation assumptions—cash and short-term investments counted in full, receivables recovered at 80%-85%, inventory discounted by 50%-70%, fixed assets discounted by 50%-60%, long-term investments valued at 70%-80%, then all liabilities subtracted—I estimate equity value at roughly KRW 70 billion to 95 billion, or about KRW 5,000-7,000 per share. This is not the value I think most likely to materialize; it is a downside reference in a permanent-capital-loss scenario.

Combining the three methods, I give the following ranges: a conservative intrinsic-value range of about KRW 7,000-12,000 per share; a fair intrinsic-value range of about KRW 12,000-18,000 per share; and an optimistic intrinsic-value range of about KRW 18,000-26,000 per share. At roughly KRW 23,700 today, the stock sits in the upper-middle part of my optimistic range and carries about a 32%-98% premium to the fair range. For a small-cap turnaround of this kind, I want to see at least a 30%-40% margin of safety, so my ideal entry range is roughly KRW 10,000-14,000 per share, my acceptable holding range is roughly KRW 14,000-18,000 per share, and above KRW 26,000 I would consider it to have entered "clearly overvalued, or at least offering no favorable odds" territory.

I must also single out dilution risk once more. The current outstanding share count is about 13.72 million shares, and the 2024 perpetual CB, if fully converted on the announced terms, would add about 9.289 million shares; this means the share count would rise by about 67.7%, and existing ordinary shareholders' economic interest after full conversion would be diluted to about 59.6%. Even though debt would fall correspondingly and the interest burden might ease, this potential dilution is enough to make "per-share intrinsic value" significantly more fragile. For a conservative investor, this alone calls for a lower entry price than for an ordinary company.

Risks, the Bear Case, and Opportunity Cost

The most important risk is not intraday volatility but that you think you are buying a high-end aerospace supplier and end up finding you have bought a project-based manufacturer that has industrial barriers but whose cash flow and per-share value remain perpetually unstable. There are several typical paths to permanent capital loss. First, competition and customer-concentration risk: public secondary sources indicate ST Engineering has become the largest customer and that a single large customer accounts for a non-trivial share of the order structure; if that customer's program cadence, order scale, pricing terms, or fleet planning change, both the income statement and cash flow would be materially affected. Second, technology/cycle risk: the PTF downturn in 2025 already put significant pressure on the company's revenue and gross margin, showing the company is not naturally immune to the aviation cycle. Third, supply-chain and execution risk: certification, delivery, and capacity ramp at primes such as Boeing affect the entire components chain; although in 2026 Boeing has raised 737 output after FAA consultations and plans to keep lifting 787 output, the transmission of such positive changes to a small supplier still usually carries execution uncertainty.

Fourth, financial and dilution risk. The company ran negative free cash flow for five straight years from 2021 to 2025, showing that business growth has not yet formed an "internally self-funding" capability; although cash-flow pressure eased in 2025 and Q1 2026, this has not yet formed a stable trajectory. Correspondingly, over the past several years the company has clearly relied on financing tools such as convertible bonds and perpetual CBs, and the share count rose from 11.78 million shares at the end of 2021 to 13.10 million shares at the end of 2025, currently about 13.72 million shares; layer on the potential full conversion of the 11th CB, and ordinary shareholders' per-share interest would face real dilution. Fifth, accounting and impairment risk: the company recorded a sizable asset impairment in 2025, showing that past investment did not all pay off as expected; another large impairment in the future would directly erode the book and market confidence.

The strongest bear case can be summed up in a single sentence: Kencoa may not be an undervalued, high-quality aerospace stock, but a capital-heavy, easily diluted, low-visibility supply-chain company wrapped in a narrative of "orders, space, SpaceX, and defense expansion." When sentiment is optimistic, investors explain the high valuation with the order story; when cash flow keeps failing to arrive, the story gives way to the statements. Under this bear framework, the key facts all favor the short side: declining margins, elevated inventory, chronically negative free cash flow, and an unresolved perpetual-CB dilution, while the valuation is not in a pessimistic deep valley.

What facts would overturn my cautious stance? I would watch these things. First, revenue growth must keep turning into cash flow: if revenue recovers significantly in 2026-2027 but operating and free cash flow still fail to turn stably positive, I would conclude that "order quality is not good enough." Second, margins must return to a provably normal level: if, after expansion, added heat-treatment capacity, and the ramp of new projects, the operating margin is still pinned below 3% over the long term, that would show it lacks sufficient pricing power and operating efficiency. Third, customer concentration must ease: if the large-customer share remains too high, or new customers are slow to contribute revenue, the risk-reward will not improve. Fourth, expansion can no longer be sustained through large-scale dilution. The moment another financing action clearly damages per-share value, I would downgrade "Watch" to "Avoid."

Against other opportunities, Kencoa's opportunity cost is not low. Stronger Korean aerospace/defense leaders such as KAI and Hanwha Aerospace are not cheap either, but at least they have achieved a higher degree of validation in scale, profitability, dividends, or platform standing; as of early June 2026, KAI had a market cap of about KRW 14.33 trillion, a P/E of about 72.43x, and pays a dividend; Hanwha Aerospace had a market cap of about KRW 55.17 trillion, a P/E of about 34.81x, and also pays a dividend. By contrast, Kencoa currently has a non-applicable P/E, negative free cash flow, and no dividend, yet the market has already granted it a not-low story valuation. For a balanced-to-conservative investor, buying it is not clearly better than buying the index or simply taking the roughly 4.1% yield on the Korean 10-year government bond. As of June 2, 2026, the Korean 10-year yield was about 4.12%-4.14%. The issue is not that Kencoa cannot outperform in the future; it is that at present it does not compensate you enough with proven cash flow.

If I could hold only five assets, it does not qualify for my portfolio. That is not because the sector is poor, but because across the four dimensions of certainty, per-share value, cash flow, and odds, at least three currently fall short of the line. Buying it is not clearly better than buying the index, nor more worthwhile than buying the risk-free yield.

Investment Checklist and Final Conclusion

The checklist itself tells the story: today Kencoa looks more like "a candidate to keep watching" than "a long-term ownership asset you can commit to heavily with confidence." Its most appealing features are entry into a high-barrier supply chain, high-quality platform customers, the improvement in Q1 2026, and rising long-term industry demand; its most fatal feature is that these strengths have not yet been proven in "free cash flow per share" and "steady growth in intrinsic value per share."

【Final Rating】 Watch

【One-Sentence Investment Thesis】 This is a turnaround small cap with the supply-chain barriers and order imagination of aerospace, but to date it has not proven it can keep converting orders into high-quality, distributable cash flow attributable to each ordinary shareholder.

【Core Bull Case】 First, the company has entered the high-barrier supply chain tied to Boeing, Lockheed, and NASA/SpaceX, and its qualifications and customer validation are real and documented; second, long-term industry demand is far from poor, with continued long-term support from global passenger and cargo traffic, fleet expansion, and conversion demand; third, the company's order pool and customer base are expanding, and businesses such as MRO, military-transport components, and aerospace raw materials have room to scale; fourth, revenue, profit, and operating cash flow all improved in Q1 2026, suggesting the worst stage may be behind it.

【Core Bear Case】 First, free cash flow was negative for five straight years from 2021 to 2025, so real cash-generation ability is unproven; second, gross and operating margins deteriorated steadily across 2023-2025, showing insufficient pricing power and cyclical resilience; third, inventory and receivables turnover worsened markedly, with growth feeding on working capital; fourth, the KRW 130 billion perpetual convertible bond implies large potential dilution, and management's path leans more toward expansion than toward compounding per-share value; fifth, the current price is not in an obviously undervalued zone and reflects turnaround expectations more than proven cash flow.

【Key Assumptions】 For the investment to hold, at least these conditions must be met: orders and backlog can steadily convert into revenue and operating cash flow over the next two years; the operating margin recovers to at least a sustainable 5%-8% range; new customers bring lower concentration rather than mere narrative expansion; once the capex peak passes, maintenance capex is significantly lower than total capex; and the company no longer relies on large-scale dilutive financing that damages per-share value.

【Fair Buy Price】 The ideal entry range I give is KRW 10,000-14,000, with a somewhat looser acceptable range of KRW 14,000-18,000. The basis is not a single multiple but a cross-check of three: first, tangible book per share at Q1 2026/year-end 2025 is around KRW 11,500-11,900; second, the conservative/base owner-earnings DCF lands at roughly that area; third, accounting for potential dilution and the volatility of a small-cap aerospace supply-chain name, I require at least a 30%-40% margin of safety.

【Target Holding Period】 If I do buy at a lower price in the future and see cash flow and margins validated, then I believe it would be suitable for a 5-10 year tracking hold; at the current price, I would rather spend the time "validating operating data" than "blindly extending the holding period."

【Expected Annualized Return】 Buying at the current price and holding for ten years, my rough judgment is: the conservative scenario about -5% to 0%; the base scenario about 2% to 5%; the optimistic scenario about 8% to 12%. These are not short-term forecasts but combined estimates based on differing degrees of cash-flow delivery, margin recovery, and valuation contraction or persistence. I do not give a higher expectation because the current price has already prepaid part of the optimistic scenario.

【Maximum Loss Risk】 In the worst case—if order delivery falls short of expectations, customer concentration causes profit to collapse, and large-scale dilution recurs—the stock could fall back toward tangible book or a harsher asset-value range of about KRW 5,000-12,000 per share. Against the current price, permanent capital loss could be roughly 50%-80%. This is not the most likely outcome, but it is a real tail risk that must be acknowledged in advance.

【Tracking Indicators】 What most deserves tracking going forward is not the share price but: whether operating cash flow turns positive on a sustained basis; whether free cash flow approaches or exceeds breakeven; whether the operating margin clears 5%; whether inventory and receivables turnover improve; whether the revenue share from customers other than ST Engineering rises; whether capex recedes from the expansion peak; whether the share count keeps expanding; whether the 11th perpetual CB begins large-scale conversion; whether new impairments recur; and the delivery quality of backlog-to-revenue conversion in 2026-2027.

【Signals That Would Trigger a Reassessment】 If the company achieves "revenue growth + positive operating cash flow + positive free cash flow + margin recovery" for two or more consecutive quarters, I would reassess and possibly upgrade the conclusion; if there is new large-scale dilutive financing, worsening customer concentration, inventory that stays high while revenue does not recover, another clear impairment, or an operating margin that remains chronically depressed before 2027, I would downgrade the conclusion from "Watch" to "Avoid."

【Final Recommendation】 Put plainly, Kencoa Aerospace is not un-investable; rather, it is not currently worth a high-priced investment under a "long-term value hold" standard. It is worth researching and worth tracking, but at this stage it looks more like a candidate on the list to "wait for a cheaper price and more cash-flow evidence" than the answer to "buy heavily today." For an investor with a horizon of ten years or more and a balanced-to-conservative profile, I would place it on the watch list rather than the core-holdings list.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.